Overview
- A Channel 4 News undercover reporter bought a counterfeit product advertised on TikTok and Meta after being added to a WhatsApp group of more than 20 sellers.
- The seller gave conflicting dosing instructions, skipped basic medical screening, and handled the vials improperly, according to the investigation.
- Eli Lilly said retatrutide is available only in clinical trials and confirmed action against suppliers Synedica and Alluvi.
- The MHRA called fake retatrutide illegal, warned of dangerous dosing or ingredients, and announced an investigation into the sales.
- TikTok and Meta removed flagged content and restricted related searches, as MPs urged ministers to press platforms to enforce online safety rules.